BUPROPION HYDROCHLORIDE au Canada
39 fiches de médicaments provenant de 14 titulaires portent ce nom dans les sources officielles. Collectées le 16 novembre 2026.
Médicaments
| Nom | Titulaire | Statut | Code |
|---|---|---|---|
| AVA-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | AVANSTRA INC | cancelled |
DIN
02363399Code de médicament DPD
84839
|
| AVA-BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | AVANSTRA INC | cancelled |
DIN
02363402Code de médicament DPD
84840
|
| BUPROPION HCL SR · 150 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02385694Code de médicament DPD
87131
|
| BUPROPION HCL XL · 150 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02383187Code de médicament DPD
86896
|
| BUPROPION HCL XL · 300 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02383195Code de médicament DPD
86895
|
| BUPROPION HYDROCHLORIDE XL · 150 MG · TABLET (EXTENDED-RELEASE) | YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. | authorised |
DIN
02561131Code de médicament DPD
106413
|
| BUPROPION HYDROCHLORIDE XL · 300 MG · TABLET (EXTENDED-RELEASE) | YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. | authorised |
DIN
02561158Code de médicament DPD
106414
|
| BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | cancelled |
DIN
02331616Code de médicament DPD
81729
|
| BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | cancelled |
DIN
02391562Code de médicament DPD
87689
|
| BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | cancelled |
DIN
02325357Code de médicament DPD
81075
|
| BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | cancelled |
DIN
02391570Code de médicament DPD
87690
|
| CONTRAVE · 8 MG + 90 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02472945Code de médicament DPD
96230
|
| DOM-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | DOMINION PHARMACAL | cancelled |
DIN
02331829Code de médicament DPD
81752
|
| DOM-BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | DOMINION PHARMACAL | cancelled |
DIN
02317761Code de médicament DPD
80330
|
| MYLAN-BUPROPION XL · 150 MG · TABLET (EXTENDED-RELEASE) | MYLAN PHARMACEUTICALS ULC | cancelled |
DIN
02382075Code de médicament DPD
86794
|
| MYLAN-BUPROPION XL · 300 MG · TABLET (EXTENDED-RELEASE) | MYLAN PHARMACEUTICALS ULC | cancelled |
DIN
02382083Code de médicament DPD
86795
|
| NOVO-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | NOVOPHARM LIMITED | cancelled |
DIN
02299461Code de médicament DPD
78486
|
| NOVO-BUPROPION SR TABLETS · 150 MG · TABLET (EXTENDED-RELEASE) | NOVOPHARM LIMITED | cancelled |
DIN
02260239Code de médicament DPD
74546
|
| ODAN BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | authorised |
DIN
02275074Code de médicament DPD
76058
|
| ODAN BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | authorised |
DIN
02275082Code de médicament DPD
76059
|
| ODAN-BUPROPION XL · 150 MG · TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | authorised |
DIN
02565838Code de médicament DPD
106839
|
| ODAN-BUPROPION XL · 300 MG · TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | authorised |
DIN
02565846Code de médicament DPD
106840
|
| PHL-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | PHARMEL INC | cancelled |
DIN
02331810Code de médicament DPD
81751
|
| PHL-BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | PHARMEL INC | cancelled |
DIN
02317788Code de médicament DPD
80331
|
| PMS-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | cancelled |
DIN
02325373Code de médicament DPD
81077
|
| PMS-BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | cancelled |
DIN
02313421Code de médicament DPD
79896
|
| PMS-BUPROPION XL · 150 MG · TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | authorised |
DIN
02573032Code de médicament DPD
107494
|
| PMS-BUPROPION XL · 300 MG · TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | authorised |
DIN
02573040Code de médicament DPD
107495
|
| RATIO-BUPROPION SR · 100 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | cancelled |
DIN
02285657Code de médicament DPD
77116
|
| RATIO-BUPROPION SR · 150 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | cancelled |
DIN
02285665Code de médicament DPD
77117
|
| TARO-BUPROPION XL · 150 MG · TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | authorised |
DIN
02475804Code de médicament DPD
96647
|
| TARO-BUPROPION XL · 300 MG · TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | authorised |
DIN
02475812Code de médicament DPD
96648
|
| TEVA-BUPROPION XL · 150 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02439654Code de médicament DPD
92405
|
| TEVA-BUPROPION XL · 300 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02439662Code de médicament DPD
92406
|
| WELLBUTRIN SR · 100 MG · TABLET (EXTENDED-RELEASE) | BIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION | cancelled |
DIN
02237824Code de médicament DPD
61183
|
| WELLBUTRIN SR · 150 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02237825Code de médicament DPD
61184
|
| WELLBUTRIN XL · 150 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02275090Code de médicament DPD
76060
|
| WELLBUTRIN XL · 300 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02275104Code de médicament DPD
76061
|
| ZYBAN · 150 MG · TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | authorised |
DIN
02238441Code de médicament DPD
61860
|
Besoin de cette liste dans votre propre système ?
Chaque fiche de cette page est disponible via l’API, avec sa source, sa licence et sa date de collecte.